Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score

Autores
Tekin, Nilgun; Omidvar, Nader; Morris, Tim Peter; Conget, Paulette; Bruna, Flavia Alejandra; Timar, Botond; Gagyi, Eva; Basak, Ranjan; Naik, Omkar; Auewarakul, Chirayu; Sritana, Narongrit; Levy, Debora; Cerci, Juliano Julio; Bydlowski, Sergio Paulo; Pereira, Juliana; Dimamay, Mark Pierre; Natividad, Filipinas; Chung, June-Key; Belder, Nevin; Kuzu, Isinsu; Paez, Diana; Dondi, Maurizio; Carr, Robert; Ozdag, Hilal; Padua, Rose Ann
Año de publicación
2016
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
As a part of an international study on the molecular analysis of Diffuse Large B-cell Lymphoma (DLBCL), a robust protocol for gene expression analysis from RNA extraction to qRT-PCR using Formalin Fixed Paraffin Embedded tissues was developed. Here a study was conducted to define a strategy to validate the previously reported 6-gene (LMO2, BCL6, FN1, CCND2, SCYA3 and BCL2) model as predictor of prognosis in DLBCL. To avoid variation, all samples were tested in a single centre and single platform. This study comprised 8 countries (Brazil, Chile, Hungary, India, Philippines, S. Korea, Thailand and Turkey). Using the Kaplan-Meier and log rank test on patients (n=162) and two mortality risk groups (with those above and below the mean representing high and low risk groups) confirmed that the 6-gene predictor score correlates significantly with overall survival (OS, p < 0.01) but not with event free survival (EFS, p=0.18). Adding the International Prognostic Index (IPI) shows that the 6-gene predictor score correlates significantly with high IPI scores for OS (p < 0.05), whereas those with low IPI scores show a trend not reaching significance (p=0.08). This study defined an effective and economical qRT-PCR strategy and validated the 6-gene score as a predictor of OS in an international setting.
Fil: Tekin, Nilgun. Ankara University. Biotechology Institute; Turquía
Fil: Omidvar, Nader. Cardiff University; Reino Unido
Fil: Morris, Tim Peter. Clinical Trials Unit at University College. Medical Research Council; Reino Unido
Fil: Conget, Paulette. Universidad del Desarrollo; Chile
Fil: Bruna, Flavia Alejandra. Universidad del Desarrollo; Chile. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina
Fil: Timar, Botond. Semmelweis University. Department of Pathology and Experimental Cancer Research; Hungría
Fil: Gagyi, Eva. Semmelweis University. Department of Pathology and Experimental Cancer Research; Hungría
Fil: Basak, Ranjan. Tata Memorial Hospital. Departments of Medical Oncology & Pathology; India
Fil: Naik, Omkar. Tata Memorial Hospital. Departments of Medical Oncology & Pathology; India
Fil: Auewarakul, Chirayu. Faculty of Medicine Sirira; Tailandia. Chulabhorn Cancer Centre; Tailandia
Fil: Sritana, Narongrit. Faculty of Medicine Sirira; Tailandia. Chulabhorn Cancer Centre; Tailandia
Fil: Levy, Debora. Chulabhorn Cancer Centre; Tailandia. Faculty of Medicine Sirira; Tailandia
Fil: Cerci, Juliano Julio. Department of Nuclear Medicine. Quanta - Diagnóstico e Terapia; Brasil
Fil: Bydlowski, Sergio Paulo. Universidade de Sao Paulo; Brasil
Fil: Pereira, Juliana. Universidade de Sao Paulo; Brasil
Fil: Dimamay, Mark Pierre. St. Lukes Medical. Research and Biotechnology Division; Filipinas
Fil: Natividad, Filipinas. St. Lukes Medical. Research and Biotechnology Division; Filipinas
Fil: Chung, June-Key. Seoul National University Hospital. Department of Nuclear Medicine; Corea del Sur
Fil: Belder, Nevin. Ankara University. Biotechology Institute; Turquía
Fil: Kuzu, Isinsu. Ankara University. Faculty of Medicina; Turquía
Fil: Paez, Diana. International Atomic Energy Agency; Austria
Fil: Dondi, Maurizio. International Atomic Energy Agency; Austria
Fil: Carr, Robert. King’s College. Guy’s & St Thomas’ Hospital; Reino Unido
Fil: Ozdag, Hilal. Ankara University. Faculty of Medicina; Turquía
Fil: Padua, Rose Ann. Institut National de la Sante Et de la Recherche Médica; Francia. Université Paris-Diderot; Francia. Institut Universitaire d'Hématologie; Francia
Materia
6-GENE PREDICTOR SCORE
DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
FORMALIN FIXED PARAFFIN EMBEDDED TISSUE (FFPE)
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/53753

id CONICETDig_59428846d94bb1389fdb493f111918ec
oai_identifier_str oai:ri.conicet.gov.ar:11336/53753
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor scoreTekin, NilgunOmidvar, NaderMorris, Tim PeterConget, PauletteBruna, Flavia AlejandraTimar, BotondGagyi, EvaBasak, RanjanNaik, OmkarAuewarakul, ChirayuSritana, NarongritLevy, DeboraCerci, Juliano JulioBydlowski, Sergio PauloPereira, JulianaDimamay, Mark PierreNatividad, FilipinasChung, June-KeyBelder, NevinKuzu, IsinsuPaez, DianaDondi, MaurizioCarr, RobertOzdag, HilalPadua, Rose Ann6-GENE PREDICTOR SCOREDIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)FORMALIN FIXED PARAFFIN EMBEDDED TISSUE (FFPE)https://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3As a part of an international study on the molecular analysis of Diffuse Large B-cell Lymphoma (DLBCL), a robust protocol for gene expression analysis from RNA extraction to qRT-PCR using Formalin Fixed Paraffin Embedded tissues was developed. Here a study was conducted to define a strategy to validate the previously reported 6-gene (LMO2, BCL6, FN1, CCND2, SCYA3 and BCL2) model as predictor of prognosis in DLBCL. To avoid variation, all samples were tested in a single centre and single platform. This study comprised 8 countries (Brazil, Chile, Hungary, India, Philippines, S. Korea, Thailand and Turkey). Using the Kaplan-Meier and log rank test on patients (n=162) and two mortality risk groups (with those above and below the mean representing high and low risk groups) confirmed that the 6-gene predictor score correlates significantly with overall survival (OS, p < 0.01) but not with event free survival (EFS, p=0.18). Adding the International Prognostic Index (IPI) shows that the 6-gene predictor score correlates significantly with high IPI scores for OS (p < 0.05), whereas those with low IPI scores show a trend not reaching significance (p=0.08). This study defined an effective and economical qRT-PCR strategy and validated the 6-gene score as a predictor of OS in an international setting.Fil: Tekin, Nilgun. Ankara University. Biotechology Institute; TurquíaFil: Omidvar, Nader. Cardiff University; Reino UnidoFil: Morris, Tim Peter. Clinical Trials Unit at University College. Medical Research Council; Reino UnidoFil: Conget, Paulette. Universidad del Desarrollo; ChileFil: Bruna, Flavia Alejandra. Universidad del Desarrollo; Chile. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; ArgentinaFil: Timar, Botond. Semmelweis University. Department of Pathology and Experimental Cancer Research; HungríaFil: Gagyi, Eva. Semmelweis University. Department of Pathology and Experimental Cancer Research; HungríaFil: Basak, Ranjan. Tata Memorial Hospital. Departments of Medical Oncology & Pathology; IndiaFil: Naik, Omkar. Tata Memorial Hospital. Departments of Medical Oncology & Pathology; IndiaFil: Auewarakul, Chirayu. Faculty of Medicine Sirira; Tailandia. Chulabhorn Cancer Centre; TailandiaFil: Sritana, Narongrit. Faculty of Medicine Sirira; Tailandia. Chulabhorn Cancer Centre; TailandiaFil: Levy, Debora. Chulabhorn Cancer Centre; Tailandia. Faculty of Medicine Sirira; TailandiaFil: Cerci, Juliano Julio. Department of Nuclear Medicine. Quanta - Diagnóstico e Terapia; BrasilFil: Bydlowski, Sergio Paulo. Universidade de Sao Paulo; BrasilFil: Pereira, Juliana. Universidade de Sao Paulo; BrasilFil: Dimamay, Mark Pierre. St. Lukes Medical. Research and Biotechnology Division; FilipinasFil: Natividad, Filipinas. St. Lukes Medical. Research and Biotechnology Division; FilipinasFil: Chung, June-Key. Seoul National University Hospital. Department of Nuclear Medicine; Corea del SurFil: Belder, Nevin. Ankara University. Biotechology Institute; TurquíaFil: Kuzu, Isinsu. Ankara University. Faculty of Medicina; TurquíaFil: Paez, Diana. International Atomic Energy Agency; AustriaFil: Dondi, Maurizio. International Atomic Energy Agency; AustriaFil: Carr, Robert. King’s College. Guy’s & St Thomas’ Hospital; Reino UnidoFil: Ozdag, Hilal. Ankara University. Faculty of Medicina; TurquíaFil: Padua, Rose Ann. Institut National de la Sante Et de la Recherche Médica; Francia. Université Paris-Diderot; Francia. Institut Universitaire d'Hématologie; FranciaImpact Journals LLC2016-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/53753Tekin, Nilgun; Omidvar, Nader; Morris, Tim Peter; Conget, Paulette; Bruna, Flavia Alejandra; et al.; Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score; Impact Journals LLC; Oncotarget; 7; 50; 11-2016; 83319-833291949-2553CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.18632/oncotarget.13066info:eu-repo/semantics/altIdentifier/url/http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=13066&path[]=42701info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:14:58Zoai:ri.conicet.gov.ar:11336/53753instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:14:58.613CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score
title Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score
spellingShingle Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score
Tekin, Nilgun
6-GENE PREDICTOR SCORE
DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
FORMALIN FIXED PARAFFIN EMBEDDED TISSUE (FFPE)
title_short Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score
title_full Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score
title_fullStr Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score
title_full_unstemmed Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score
title_sort Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score
dc.creator.none.fl_str_mv Tekin, Nilgun
Omidvar, Nader
Morris, Tim Peter
Conget, Paulette
Bruna, Flavia Alejandra
Timar, Botond
Gagyi, Eva
Basak, Ranjan
Naik, Omkar
Auewarakul, Chirayu
Sritana, Narongrit
Levy, Debora
Cerci, Juliano Julio
Bydlowski, Sergio Paulo
Pereira, Juliana
Dimamay, Mark Pierre
Natividad, Filipinas
Chung, June-Key
Belder, Nevin
Kuzu, Isinsu
Paez, Diana
Dondi, Maurizio
Carr, Robert
Ozdag, Hilal
Padua, Rose Ann
author Tekin, Nilgun
author_facet Tekin, Nilgun
Omidvar, Nader
Morris, Tim Peter
Conget, Paulette
Bruna, Flavia Alejandra
Timar, Botond
Gagyi, Eva
Basak, Ranjan
Naik, Omkar
Auewarakul, Chirayu
Sritana, Narongrit
Levy, Debora
Cerci, Juliano Julio
Bydlowski, Sergio Paulo
Pereira, Juliana
Dimamay, Mark Pierre
Natividad, Filipinas
Chung, June-Key
Belder, Nevin
Kuzu, Isinsu
Paez, Diana
Dondi, Maurizio
Carr, Robert
Ozdag, Hilal
Padua, Rose Ann
author_role author
author2 Omidvar, Nader
Morris, Tim Peter
Conget, Paulette
Bruna, Flavia Alejandra
Timar, Botond
Gagyi, Eva
Basak, Ranjan
Naik, Omkar
Auewarakul, Chirayu
Sritana, Narongrit
Levy, Debora
Cerci, Juliano Julio
Bydlowski, Sergio Paulo
Pereira, Juliana
Dimamay, Mark Pierre
Natividad, Filipinas
Chung, June-Key
Belder, Nevin
Kuzu, Isinsu
Paez, Diana
Dondi, Maurizio
Carr, Robert
Ozdag, Hilal
Padua, Rose Ann
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv 6-GENE PREDICTOR SCORE
DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
FORMALIN FIXED PARAFFIN EMBEDDED TISSUE (FFPE)
topic 6-GENE PREDICTOR SCORE
DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
FORMALIN FIXED PARAFFIN EMBEDDED TISSUE (FFPE)
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv As a part of an international study on the molecular analysis of Diffuse Large B-cell Lymphoma (DLBCL), a robust protocol for gene expression analysis from RNA extraction to qRT-PCR using Formalin Fixed Paraffin Embedded tissues was developed. Here a study was conducted to define a strategy to validate the previously reported 6-gene (LMO2, BCL6, FN1, CCND2, SCYA3 and BCL2) model as predictor of prognosis in DLBCL. To avoid variation, all samples were tested in a single centre and single platform. This study comprised 8 countries (Brazil, Chile, Hungary, India, Philippines, S. Korea, Thailand and Turkey). Using the Kaplan-Meier and log rank test on patients (n=162) and two mortality risk groups (with those above and below the mean representing high and low risk groups) confirmed that the 6-gene predictor score correlates significantly with overall survival (OS, p < 0.01) but not with event free survival (EFS, p=0.18). Adding the International Prognostic Index (IPI) shows that the 6-gene predictor score correlates significantly with high IPI scores for OS (p < 0.05), whereas those with low IPI scores show a trend not reaching significance (p=0.08). This study defined an effective and economical qRT-PCR strategy and validated the 6-gene score as a predictor of OS in an international setting.
Fil: Tekin, Nilgun. Ankara University. Biotechology Institute; Turquía
Fil: Omidvar, Nader. Cardiff University; Reino Unido
Fil: Morris, Tim Peter. Clinical Trials Unit at University College. Medical Research Council; Reino Unido
Fil: Conget, Paulette. Universidad del Desarrollo; Chile
Fil: Bruna, Flavia Alejandra. Universidad del Desarrollo; Chile. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina
Fil: Timar, Botond. Semmelweis University. Department of Pathology and Experimental Cancer Research; Hungría
Fil: Gagyi, Eva. Semmelweis University. Department of Pathology and Experimental Cancer Research; Hungría
Fil: Basak, Ranjan. Tata Memorial Hospital. Departments of Medical Oncology & Pathology; India
Fil: Naik, Omkar. Tata Memorial Hospital. Departments of Medical Oncology & Pathology; India
Fil: Auewarakul, Chirayu. Faculty of Medicine Sirira; Tailandia. Chulabhorn Cancer Centre; Tailandia
Fil: Sritana, Narongrit. Faculty of Medicine Sirira; Tailandia. Chulabhorn Cancer Centre; Tailandia
Fil: Levy, Debora. Chulabhorn Cancer Centre; Tailandia. Faculty of Medicine Sirira; Tailandia
Fil: Cerci, Juliano Julio. Department of Nuclear Medicine. Quanta - Diagnóstico e Terapia; Brasil
Fil: Bydlowski, Sergio Paulo. Universidade de Sao Paulo; Brasil
Fil: Pereira, Juliana. Universidade de Sao Paulo; Brasil
Fil: Dimamay, Mark Pierre. St. Lukes Medical. Research and Biotechnology Division; Filipinas
Fil: Natividad, Filipinas. St. Lukes Medical. Research and Biotechnology Division; Filipinas
Fil: Chung, June-Key. Seoul National University Hospital. Department of Nuclear Medicine; Corea del Sur
Fil: Belder, Nevin. Ankara University. Biotechology Institute; Turquía
Fil: Kuzu, Isinsu. Ankara University. Faculty of Medicina; Turquía
Fil: Paez, Diana. International Atomic Energy Agency; Austria
Fil: Dondi, Maurizio. International Atomic Energy Agency; Austria
Fil: Carr, Robert. King’s College. Guy’s & St Thomas’ Hospital; Reino Unido
Fil: Ozdag, Hilal. Ankara University. Faculty of Medicina; Turquía
Fil: Padua, Rose Ann. Institut National de la Sante Et de la Recherche Médica; Francia. Université Paris-Diderot; Francia. Institut Universitaire d'Hématologie; Francia
description As a part of an international study on the molecular analysis of Diffuse Large B-cell Lymphoma (DLBCL), a robust protocol for gene expression analysis from RNA extraction to qRT-PCR using Formalin Fixed Paraffin Embedded tissues was developed. Here a study was conducted to define a strategy to validate the previously reported 6-gene (LMO2, BCL6, FN1, CCND2, SCYA3 and BCL2) model as predictor of prognosis in DLBCL. To avoid variation, all samples were tested in a single centre and single platform. This study comprised 8 countries (Brazil, Chile, Hungary, India, Philippines, S. Korea, Thailand and Turkey). Using the Kaplan-Meier and log rank test on patients (n=162) and two mortality risk groups (with those above and below the mean representing high and low risk groups) confirmed that the 6-gene predictor score correlates significantly with overall survival (OS, p < 0.01) but not with event free survival (EFS, p=0.18). Adding the International Prognostic Index (IPI) shows that the 6-gene predictor score correlates significantly with high IPI scores for OS (p < 0.05), whereas those with low IPI scores show a trend not reaching significance (p=0.08). This study defined an effective and economical qRT-PCR strategy and validated the 6-gene score as a predictor of OS in an international setting.
publishDate 2016
dc.date.none.fl_str_mv 2016-11
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/53753
Tekin, Nilgun; Omidvar, Nader; Morris, Tim Peter; Conget, Paulette; Bruna, Flavia Alejandra; et al.; Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score; Impact Journals LLC; Oncotarget; 7; 50; 11-2016; 83319-83329
1949-2553
CONICET Digital
CONICET
url http://hdl.handle.net/11336/53753
identifier_str_mv Tekin, Nilgun; Omidvar, Nader; Morris, Tim Peter; Conget, Paulette; Bruna, Flavia Alejandra; et al.; Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score; Impact Journals LLC; Oncotarget; 7; 50; 11-2016; 83319-83329
1949-2553
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.18632/oncotarget.13066
info:eu-repo/semantics/altIdentifier/url/http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=13066&path[]=42701
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Impact Journals LLC
publisher.none.fl_str_mv Impact Journals LLC
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844614082466938880
score 13.070432